2019
DOI: 10.1111/acel.13017
|View full text |Cite
|
Sign up to set email alerts
|

Telomere length and aging‐related outcomes in humans: A Mendelian randomization study in 261,000 older participants

Abstract: Inherited genetic variation influencing leukocyte telomere length provides a natural experiment for testing associations with health outcomes, more robust to confounding and reverse causation than observational studies. We tested associations between genetically determined telomere length and aging‐related health outcomes in a large European ancestry older cohort. Data were from n = 379,758 UK Biobank participants aged 40–70, followed up for mean of 7.5 years (n = 261,837 participants aged 60 and older by end … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
75
0
2

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 86 publications
(80 citation statements)
references
References 46 publications
3
75
0
2
Order By: Relevance
“…Although the molecular mechanism remains unclear, some prior studies implied that both short and long telomere length played an important role in the etiology of cancers (Cui et al, 2012;Cheng et al, 2017;Nelson and Codd, 2020). Cells with longer telomere lengths have greater proliferative potential and more probability of accruing mutations (Hanahan and Weinberg, 2011); therefore, telomere shortening is generally considered to be a protective mechanism against tumorigenesis (Rode et al, 2016;Zhang et al, 2017;Kuo et al, 2019). However, it has been proposed that telomere shortening can generally give rise to end-to-end chromosome fusions and attenuates DNA damage response, thus increasing genomic instability and finally initiating carcinogenesis (Wu et al, 2003).…”
Section: Discoveries Combined With the Previous Studymentioning
confidence: 99%
“…Although the molecular mechanism remains unclear, some prior studies implied that both short and long telomere length played an important role in the etiology of cancers (Cui et al, 2012;Cheng et al, 2017;Nelson and Codd, 2020). Cells with longer telomere lengths have greater proliferative potential and more probability of accruing mutations (Hanahan and Weinberg, 2011); therefore, telomere shortening is generally considered to be a protective mechanism against tumorigenesis (Rode et al, 2016;Zhang et al, 2017;Kuo et al, 2019). However, it has been proposed that telomere shortening can generally give rise to end-to-end chromosome fusions and attenuates DNA damage response, thus increasing genomic instability and finally initiating carcinogenesis (Wu et al, 2003).…”
Section: Discoveries Combined With the Previous Studymentioning
confidence: 99%
“…TL is associated with some, but not all, ageing and disease-related traits [13,14]. Literature is inconsistent regarding TL and all-cause mortality with some [7,15] but not all studies [16,17] finding that a shorter TL is associated with increased risk of all-cause mortality.…”
Section: Introductionmentioning
confidence: 99%
“…While in cancer the literature is conflicted regarding risk of cancer and TL [7,[21][22][23] with suggestions that perhaps a "Ushaped" risk association may exist between very short and very long telomeres and risk of different types cancer [12,22,24,25]. In two recent papers, there was no association between TL and cognitive function, grip strength, frailty and sarcopenia [13,26]; suggesting that telomere length may not be a marker of all ageing and disease-related traits.…”
Section: Introductionmentioning
confidence: 99%
“…This predictive score could then be compared to chronological age to estimate "accelerated ageing" of the antibody repertoire, or immune age. Similar "biological age" metrics based on cell counts, gene expression, cytokine expression, blood and leukocyte epigenetics, telomere length, and genetic predispositions thereof have been found to be predictive of health, disease, and even all-cause mortality [33][34][35][36][37][38][39][40][41], suggesting that molecular correlates of age can be useful biomarkers.…”
Section: Machine Learning Model Of Serum Antibody Binding Predicts Chmentioning
confidence: 83%